Farmaceutische ontwikkelingen profiteren van iSWAB-RNA v2-monsters bij kankeronderzoek

HAYWARD, Californië – (BUSINESS WIRE) – Mawi DNA Technologies, een biotechnologiebedrijf dat zich richt op de ontwikkeling van innovatieve technologieën voor biosampling, kondigt aan dat MagBio Genomics met succes een geautomatiseerde RNA-zuiveringsmethode heeft ontwikkeld voor iSWAB-RNA v2 op de Thermofisher KingFisher™ Flex platform met zijn HighPrep™ Total RNA Isolation Kit – iSWAB™.

De iSWAB-RNA v2 van Mawi DNA Technologies maakt niet-invasieve zelfverzameling, concentratie en stabilisatie mogelijk van intacte buccale cellen en/of alle zoogdiercellen die zijn verzameld met een wattenstaafje of een cytoborstel. Het maakt tot vier weken real-time omgevingsstabilisatie van totaal RNA mogelijk vanaf het punt van verzameling tot verwerking. Het hoogwaardige RNA dat wordt geëxtraheerd uit gestabiliseerde iSWAB-RNA v2-monsters is geschikt voor genexpressie-toepassingen zoals real-time kwantitatieve PCR, reverse transcriptie PCR, microarrays, Northern blot-analyse, nuclease-beschermingstesten, cDNA-bibliotheekconstructie en RNA-seq.

MagBio Genomics Inc. Develops Automated RNA Purification Chemistry for Mawi iSWAB-RNA v2 on Thermofisher KingFisher™ Flex

Pharmaceutical Developments Benefit From iSWAB-RNA v2 Samples In Cancer Research

HAYWARD, Calif.–(BUSINESS WIRE)– Mawi DNA Technologies, a biotechnology company focusing on the development of innovative technologies for biosampling, announces that MagBio Genomics has successfully developed an automated RNA purification method for iSWAB-RNA v2 on the Thermofisher KingFisher™ Flex platform with its HighPrep™ Total RNA Isolation Kit – iSWAB™.

Mawi DNA Technologies’ iSWAB-RNA v2 allows for non-invasive self collection, concentration, and stabilization of intact buccal cells and/or any mammalian cells collected with a swab or cytobrush. It enables up to four weeks of real-time ambient stabilization of total RNA from the point of collection to processing. The high-quality RNA extracted from stabilized iSWAB-RNA v2 samples is suitable for gene expression applications such as real-time quantitative PCR, reverse transcription PCR, microarrays, northern blot analysis, nuclease protection assays, cDNA library construction and RNA-seq.

“Collaborating with MagBio Genomics to optimize their HighPrep™ Total RNA Plus Kit-iSWAB™ for iSWAB-RNA v2 was a no-brainer for us, especially because it provides a great option for our high throughput end users like pharma and CROs,” said Dr. Bassam El-Fahmawi, President and CTO, Mawi DNA Technologies. “Partnerships with leaders in nucleic acid purification chemistries with a global presence, such as MagBio Genomics, are increasing worldwide access of our sample collection technologies, which results in better understanding of health and wellness at a global rather than at a regional level.” El-Fahmawi said that due to increased sample sizes in cohort genetic population studies, there is an increasing need for automated RNA purification solutions. The MagBio HighPrep Total RNA Plus Kit-iSWAB™ simplifies this research step, which can be labor-intensive.

“MagBio has successfully developed and optimized the HighPrep™ Total RNA Isolation Kit-iSWAB™ for extraction of total RNA from iSWAB-RNA v2 samples on Thermofisher KingFisher™ Flex Purification System,” said Dr. Mothomang Mlalazi-Oyinloye, Associate Scientific Director, MagBio Genomics. “This new method is being used by a major pharmaceutical company to process iSWAB-RNA v2 samples for elucidation of molecular mechanisms of cancer development. With this automated protocol, 96 samples can be run in less than one hour.” She added that the extracted RNA is of high purity and quality and is compatible with complex and sensitive assays. RNA yields up to 1ug per sample are obtained (Qubit RNA Broad Assay).

“We are expanding our automated methods library to include the most commonly used lab automation systems,” Dr. Mlalazi-Oyinloye said. “iSWAB-RNA v2 is the non-invasive sample collection alternative to venipuncture and tissue biopsy our fellow researchers have been looking for which maintains RNA integrity especially during long transit times. MagBio Genomics is all about making the next generation sequencing workflow better. We developed an automated method for simplifying RNA purification from iSWAB-RNA v2 samples using our HighPrep™ Total RNA Plus Kit-iSWAB™,” said Dr. Hyacinth Ntchobo, CEO, MagBio Genomics. He added that when used in combination, Mawi’s iSWAB-RNA v2 collection technology and MagBio Genomics’ purification chemistry provide an efficient workflow for high throughput purification of high-quality RNA for demanding downstream applications.

About MagBio Genomics Inc.

MagBio Genomics is a global company that develops and commercializes magnetic bead-based products for nucleic acid isolation including biomarkers as tools for liquid biopsy genomic research. The current focus encompasses products that cover the complete sample preparation for NGS; from allowing safeguarding integrity of bio-samples, efficient isolation of circulating biomarkers to target enrichment from biological samples. Products are applied to human genetic research including cancer genomic studies and non-invasive prenatal testing (NIPT).“WE SIMPLY MAKE NGS BETTER.” For more information, visit http://www.magbiogenomics.com.

About Mawi DNA Technologies

Mawi DNA Technologies has developed and commercialized the iSWAB technology, an innovative system for collection of biosamples. Flagship product iSWAB-DNA has gained significant market traction due to its ability to be used for animals and all human population segments from infants to the elderly, with robust DNA yield and low bacterial DNA content. Mawi DNA has established relationships with children’s hospitals for neonatal screening and has an extensive global network of international distributors to market and sell iSWAB products. For more information, visit http://www.mawidna.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210511005456/en/

Contacts

Susan Tellem, APR, RN, BSN

310-313-3444 x1, Susan@tellemgrodypr.com